177 related articles for article (PubMed ID: 32887159)
1. Sensors in heart-on-a-chip: A review on recent progress.
Cho KW; Lee WH; Kim BS; Kim DH
Talanta; 2020 Nov; 219():121269. PubMed ID: 32887159
[TBL] [Abstract][Full Text] [Related]
2. Heart-on-Chip for Combined Cellular Dynamics Measurements and Computational Modeling Towards Clinical Applications.
Park J; Wu Z; Steiner PR; Zhu B; Zhang JXJ
Ann Biomed Eng; 2022 Feb; 50(2):111-137. PubMed ID: 35039976
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous electrical recording of cardiac electrophysiology and contraction on chip.
Qian F; Huang C; Lin YD; Ivanovskaya AN; O'Hara TJ; Booth RH; Creek CJ; Enright HA; Soscia DA; Belle AM; Liao R; Lightstone FC; Kulp KS; Wheeler EK
Lab Chip; 2017 May; 17(10):1732-1739. PubMed ID: 28448074
[TBL] [Abstract][Full Text] [Related]
4. Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of physiological function.
Zhang F; Qu KY; Zhou B; Luo Y; Zhu Z; Pan DJ; Cui C; Zhu Y; Chen ML; Huang NP
Biosens Bioelectron; 2021 May; 179():113080. PubMed ID: 33639347
[TBL] [Abstract][Full Text] [Related]
5. From cardiac tissue engineering to heart-on-a-chip: beating challenges.
Zhang YS; Aleman J; Arneri A; Bersini S; Piraino F; Shin SR; Dokmeci MR; Khademhosseini A
Biomed Mater; 2015 Jun; 10(3):034006. PubMed ID: 26065674
[TBL] [Abstract][Full Text] [Related]
6. Towards chamber specific heart-on-a-chip for drug testing applications.
Zhao Y; Rafatian N; Wang EY; Wu Q; Lai BFL; Lu RX; Savoji H; Radisic M
Adv Drug Deliv Rev; 2020; 165-166():60-76. PubMed ID: 31917972
[TBL] [Abstract][Full Text] [Related]
7. Flexible Electronics toward Wearable Sensing.
Gao W; Ota H; Kiriya D; Takei K; Javey A
Acc Chem Res; 2019 Mar; 52(3):523-533. PubMed ID: 30767497
[TBL] [Abstract][Full Text] [Related]
8. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
[TBL] [Abstract][Full Text] [Related]
9. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
Clements M; Millar V; Williams AS; Kalinka S
Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
[TBL] [Abstract][Full Text] [Related]
10. High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.
Conant G; Lai BFL; Lu RXZ; Korolj A; Wang EY; Radisic M
Stem Cell Rev Rep; 2017 Jun; 13(3):335-346. PubMed ID: 28429185
[TBL] [Abstract][Full Text] [Related]
11. Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring.
Liu Y; Pharr M; Salvatore GA
ACS Nano; 2017 Oct; 11(10):9614-9635. PubMed ID: 28901746
[TBL] [Abstract][Full Text] [Related]
12. Skin-Mountable Biosensors and Therapeutics: A Review.
Lee EK; Kim MK; Lee CH
Annu Rev Biomed Eng; 2019 Jun; 21():299-323. PubMed ID: 30883212
[TBL] [Abstract][Full Text] [Related]
13. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
[TBL] [Abstract][Full Text] [Related]
14. Lab-on-fiber technology: a new vision for chemical and biological sensing.
Ricciardi A; Crescitelli A; Vaiano P; Quero G; Consales M; Pisco M; Esposito E; Cusano A
Analyst; 2015 Dec; 140(24):8068-79. PubMed ID: 26514109
[TBL] [Abstract][Full Text] [Related]
15. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
Yang X; Papoian T
J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
[TBL] [Abstract][Full Text] [Related]
16. Step-by-step fabrication of heart-on-chip systems as models for cardiac disease modeling and drug screening.
Deir S; Mozhdehbakhsh Mofrad Y; Mashayekhan S; Shamloo A; Mansoori-Kermani A
Talanta; 2024 Jan; 266(Pt 1):124901. PubMed ID: 37459786
[TBL] [Abstract][Full Text] [Related]
17. Packaging commercial CMOS chips for lab on a chip integration.
Datta-Chaudhuri T; Abshire P; Smela E
Lab Chip; 2014 May; 14(10):1753-66. PubMed ID: 24682025
[TBL] [Abstract][Full Text] [Related]
18. On-chip in vitro cell-network pre-clinical cardiac toxicity using spatiotemporal human cardiomyocyte measurement on a chip.
Kaneko T; Nomura F; Hamada T; Abe Y; Takamori H; Sakakura T; Takasuna K; Sanbuissho A; Hyllner J; Sartipy P; Yasuda K
Sci Rep; 2014 Apr; 4():4670. PubMed ID: 24751527
[TBL] [Abstract][Full Text] [Related]
19. In Situ LSPR Sensing of Secreted Insulin in Organ-on-Chip.
Ortega MA; Rodríguez-Comas J; Yavas O; Velasco-Mallorquí F; Balaguer-Trias J; Parra V; Novials A; Servitja JM; Quidant R; Ramón-Azcón J
Biosensors (Basel); 2021 Apr; 11(5):. PubMed ID: 33924867
[TBL] [Abstract][Full Text] [Related]
20. Soft and flexible material-based affinity sensors.
Meng L; Turner APF; Mak WC
Biotechnol Adv; 2020; 39():107398. PubMed ID: 31071431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
